Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 2nd Quarter - Report (No Activity)

ENDO INTERNATIONAL

via ENDO INTERNATIONAL

2nd Quarter (Apr 1 - June 30) · 2019Posted Jul 22, 2019Filing document ↗LDA record ↗

Expenses$140Kself-filed spend

Client

Name: ENDO INTERNATIONAL
Location: Pennsylvania · United States of America

Registrant

Firm: ENDO INTERNATIONAL
Description: Pharmaceutical company
Location: Malvern, Pennsylvania, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

ENDO INTERNATIONAL — Lobbying — Receipts Report